search
Back to results

Anti-Obesity Effect of Pediococcus Pentosaceus LP28

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
Live Pediococcus pentosaceus LP28
Heat-killed Pediococcus pentosaceus LP28
Placebo
Sponsored by
Hiroshima University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Obesity

Eligibility Criteria

20 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • BMI 25-30 kg/m2

Exclusion Criteria:

  • Taking medicines or functional food that may affect body weight or body fat
  • Pregnant or nursing a child
  • Participation in any clinical trial within 90 days of the commencement of the trial
  • Renal or hepatic dysfunction
  • Heart disease

Sites / Locations

  • Hiroshima University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Experimental

Experimental

Arm Label

Placebo

Live Pediococcus pentosaceus LP28

Heat-killed Pediococcus pentosaceus LP28

Arm Description

Outcomes

Primary Outcome Measures

Body fat
BMI
Body weight will be measured every morning.

Secondary Outcome Measures

Abdominal circumference
Serum triglyceride
Total cholesterol
LDL cholesterol
HDL cholesterol
Fasting blood glucose
Fasting insulin
HOMA-R
Adiponectin
Leptin
Resistin

Full Information

First Posted
September 12, 2012
Last Updated
February 25, 2016
Sponsor
Hiroshima University
search

1. Study Identification

Unique Protocol Identification Number
NCT01685944
Brief Title
Anti-Obesity Effect of Pediococcus Pentosaceus LP28
Official Title
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Pediococcus Pentosaceus LP28 on Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
April 2013 (Actual)
Study Completion Date
April 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hiroshima University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is designed to evaluate efficacy of Pediococcus pentosaceus LP28 in reducing body fat and body weight in subjects with BMI 25-30 kg/m2.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
62 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Title
Live Pediococcus pentosaceus LP28
Arm Type
Experimental
Arm Title
Heat-killed Pediococcus pentosaceus LP28
Arm Type
Experimental
Intervention Type
Dietary Supplement
Intervention Name(s)
Live Pediococcus pentosaceus LP28
Intervention Type
Dietary Supplement
Intervention Name(s)
Heat-killed Pediococcus pentosaceus LP28
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
Body fat
Time Frame
Every 4 weeks (Overall 12 weeks)
Title
BMI
Description
Body weight will be measured every morning.
Time Frame
Every day (Overall 14 weeks)
Secondary Outcome Measure Information:
Title
Abdominal circumference
Time Frame
Every 4 weeks (Overall 12 weeks)
Title
Serum triglyceride
Time Frame
Every 4 weeks (Overall 12 weeks)
Title
Total cholesterol
Time Frame
Every 4 weeks (Overall 12 weeks)
Title
LDL cholesterol
Time Frame
Every 4 weeks (Overall 12 weeks)
Title
HDL cholesterol
Time Frame
Every 4 weeks (Overall 12 weeks)
Title
Fasting blood glucose
Time Frame
Every 4 weeks (Overall 12 weeks)
Title
Fasting insulin
Time Frame
Weeks 0 and 12
Title
HOMA-R
Time Frame
Weeks 0 and 12
Title
Adiponectin
Time Frame
Weeks 0 and 12
Title
Leptin
Time Frame
Weeks 0 and 12
Title
Resistin
Time Frame
Weeks 0 and 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: BMI 25-30 kg/m2 Exclusion Criteria: Taking medicines or functional food that may affect body weight or body fat Pregnant or nursing a child Participation in any clinical trial within 90 days of the commencement of the trial Renal or hepatic dysfunction Heart disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fumiko Higashikawa, PhD
Organizational Affiliation
Hiroshima University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hiroshima University
City
Hiroshima
ZIP/Postal Code
734-8551
Country
Japan

12. IPD Sharing Statement

Learn more about this trial

Anti-Obesity Effect of Pediococcus Pentosaceus LP28

We'll reach out to this number within 24 hrs